Tertiary-butylhydroquinone
Antioxidant
Allergy/RespiratoryCarcinogenUnclear/Controversial
Description
Tertiary-butylhydroquinone, or TBHQ, is a synthetic preservative added to fats and oils to prevent them from going rancid. It is a type of phenol used to extend the shelf life of many processed foods, including fast-food frying oils, crackers, chips, and frozen meats. The FDA permits its use up to a limit of 0.02% of a food's fat content. While effective at preserving food quality, a growing body of scientific research has raised concerns about its potential effects on the immune system, particularly regarding allergic reactions and response to infections.
Learn More Dossier
Aliases / Common Names: t-Butylhydroquinone, TBHQ, E319, Mono-tert-butylhydroquinone, 2-(1,1-dimethylethyl)-1,4-benzenediol
Regulatory Status & Exposure: The FDA approved TBHQ in 1972 and regulates its use under 21 CFR 172.185, limiting it to 0.02% (200 ppm) of the fat content in food. The Joint FAO/WHO Expert Committee on Food Additives (JECFA) established an Acceptable Daily Intake (ADI) of 0.7 mg/kg of body weight in 1997, which was later confirmed by the European Food Safety Authority (EFSA) in 2004. While average U.S. intake is likely below this ADI, estimates suggest that individuals on high-fat diets, a characteristic of many fast-food consumers, may exceed it. TBHQ is not banned for safety in the EU or Canada.
Technical Evidence: The toxicological profile of TBHQ is complex. The most comprehensive long-term study by the National Toxicology Program (NTP) found no evidence of carcinogenic activity in rats or mice. However, a significant body of recent research points to immunotoxicity as a primary concern. Animal studies have shown that dietary TBHQ at human-relevant exposure levels can exacerbate allergic sensitization and anaphylaxis, an effect linked to its activation of the Nrf2 pathway, which promotes a Th2-type immune response. Other studies suggest TBHQ may impair T-cell activation, potentially weakening the immune response to infections like influenza and reducing vaccine efficacy. Some in-vitro studies have also shown it can cause chromosomal damage in mammalian cells after metabolic activation.
Fast-Food Context: TBHQ is highly prevalent in the fast-food industry due to its effectiveness in stabilizing frying oils, which are subjected to high heat and repeated use. Adding TBHQ to oil blends for items like french fries and chicken nuggets extends the oil's life, reducing costs and maintaining product consistency. This practice makes fast-food meals a significant and frequent source of TBHQ exposure for many consumers, increasing the likelihood of high-intake individuals exceeding the established ADI.
Sensitive Populations / Notes: Individuals with pre-existing allergies or compromised immune systems may be more susceptible to the potential immunomodulatory effects of TBHQ. Due to their lower body weight and potentially high consumption of processed foods relative to their size, children may have higher exposure levels, and EFSA has noted they are the group most likely to exceed the ADI in high-intake scenarios.
Regulatory status
United States
Allowed
Permitted in foods (antioxidant in fats/oils up to 0.02%)
Basis: 21 CFR 172.185
Source
European Union
Allowed
Authorized in specific food categories (oils, cake mixes, etc.) up to 200 mg/kg fat
Basis: Efsa Opinion
Source
Japan
Banned
Food additive not approved for use in foods
Basis: Other
Registry review date: 2026-01-18
Policy timeline
-
2025-07-10 — H.R. 4306 (Food Chemical Reassessment Act) introduced
(United States)
-
2026-01-05 — Indiana HB 1137 introduced (school TBHQ restriction)
(US-IN)
Research Evidence Snapshot
Animal studies show TBHQ is largely safe at low doses but causes adverse effects (tumors, organ toxicity) at high doses. Emerging research (2021-2022) indicates potential immunomodulatory effects, including suppression of T-cell function and altered response to viral infections. Human data are minimal, and federal re-evaluation is proposed as of 2025.
Critical endpoints: Forestomach tumors (rodents), liver enlargement (adaptive changes), immunomodulation (T-cell suppression), positive/negative genotoxicity assays.
ACUTE SENSITIVITY HAZARD
Confidence: High
None known
No immediate allergic or sensitivity reactions to TBHQ have been documented at typical exposure levels.
CHRONIC HEALTH EVIDENCE DIRECTION
Confidence: Moderate
Neutral/unclear
Long-term animal studies show no harm at low doses, but high-dose effects and new immunological findings (T-cell suppression) create some uncertainty.
EVIDENCE STRENGTH
Confidence: High
Moderate
Safety assessments are based on several animal studies and regulatory evaluations (FDA, EFSA), but human data are limited and emerging immune evidence is primarily animal-based.
REGULATORY POSTURE (U.S.)
Confidence: High
Authorized/Permitted
Listed as an approved antioxidant in U.S. regulations (21 CFR 172.185) for use in foods up to 0.02% of fat content.
REGULATORY DIVERGENCE
Confidence: High
Moderate
Allowed in U.S. and EU (with limits), but banned in Japan. TBHQ is a priority for FDA re-evaluation under the 2025 federal Food Chemical Reassessment Act and is included in Indiana's 2026 school-meal restriction proposal (HB 1137).
HEALTH-BASED GUIDANCE AVAILABILITY
Confidence: High
Established
Global authorities have set an ADI (0.7 mg/kg bw/day), providing a clear safety benchmark.
EXPOSURE CERTAINTY
Confidence: Moderate
Moderate
Intake estimates exist and generally fall below the ADI, but measured data (especially for restaurant foods) are limited, leading to moderate uncertainty in actual exposure.
DATA RECENCY & STABILITY
Confidence: Moderate
Evolving
Core toxicology data are older but re-evaluated in mid-2010s; recent studies (2021-2022) on immune effects suggest the risk profile is being revisited.
Health guidance & exposure
Agency exposure estimates
- EFSA — Adult high-percentile: 50 % ADI
Fast-food usage levels are not publicly disclosed, introducing uncertainty in exposure assessment.
Data gaps
- Human epidemiological or clinical studies on long-term TBHQ consumption
- Up-to-date measurements of TBHQ in prepared foods (restaurant and retail)
- Further research on immunological and metabolic outcomes in vivo
Found in these Restaurants
We found this ingredient in menu items at the following chains:
Methodology
We assign the Moderate Concern tier using published research, regulatory guidance, and PRūF’s additive taxonomy. Restaurant usage is derived from public ingredient disclosures and mapped to menu items where this additive appears.
Browse all restaurant audits
Related questions and pages
Regulatory context
Learn how this additive is treated across different regulatory frameworks and why mixture effects can matter.
Scientific Sources & References
About this Audit
Data sourced from publicly available nutrition guides and ingredient lists as of 2026-03-04. Percentages represent the frequency of an ingredient's appearance across standard menu items, not the quantity within a specific item. Regional availability and supplier formulations may vary.
PRūF is an independent educational tool and is not affiliated with, endorsed by, or connected to any restaurant chain mentioned. All trademarks belong to their respective owners.
